Back
Speaker illustration

Doctor Rasha Kaddoura

HMC Heart Hospital, Doha (Qatar)

Member of:

European Society of Cardiology

Rasha Kaddoura, MSc (Pharm), Pharm D, is a clinical pharmacy specialist at the Heart Hospital, serving in the in-patient and out-patient settings. In addition to COVID-19 facilities during the pandemic. Rasha received her Post-Graduate Doctor of Pharmacy degree from the University of Toronto and her Masters Degree in Clinical Pharmacy from Szeged University – Hungary. Currently, a Master’s study candidate to pursue a degree in clinical research. Licensed and practised in Hungary, Canada and Qatar. In addition to being a pharmacy board-certified in Lebanon. Her expertise also includes drug information, drug utilization review, and medication therapy management. Served in three hospital committees, involved in preparing, updating and reviewing clinical practice guidelines, and variety of pharmacy and non-pharmacy projects. She has several published papers and served as preceptor for pharmacy undergraduate, Masters’ and Pharm D students, as well as preceptor for PGY-pharmacy residents.

Presentations Articles

A comparative analysis of the characteristics and outcomes of de novo heart failure versus acutely decompensated chronic heart failure

Event: ESC Congress 2025

Topic: Epidemiology, Prognosis, Outcome

Session: Characterising subpopulations in heart failure

Access
Like
Thumbnail

Impact of cardiogenic shock on outcomes in patients with spontaneous coronary artery dissection: a systematic review and meta-analysis

Event: ESC Congress 2025

Topic: Spontaneous Coronary Artery Dissection (SCAD)

Session: Non-obstructive coronary artery disease and acute coronary syndromes (2)

Access
Like
Thumbnail

Transcatheter aortic valve implantation in failed bioprosthetic or native valves: a systematic review and meta analysis

Event: ESC Congress 2024

Topic: Aortic Valve Intervention

Session: TAVI vs. SAVR: still unresolved question?

Access
Like
Thumbnail

Temporal trends in characteristics and outcomes in patients undergoing percutaneous mitral valve repair for secondary mitral regurgitation

Event: ESC Congress 2023

Topic: Mitral Valve Intervention

Session: Mitral valve transcatheter edge-to-edge repair

Access
Like
Thumbnail

Transcatheter mitral-valve repair for functional mitral regurgitation data from the real-life in comparison with landmark randomized trials

Event: ESC Congress 2022

Topic: Mitral Valve Intervention

Session: Mitral valve interventions / TEER

Access
Like
Thumbnail

Intracoronary pharmacological therapy versus aspiration thrombectomy in patients presenting with ST-segment elevation myocardial infarction (IPAT-STEMI): a systematic review and meta-analysis

Event: ESC Congress 2021 - The Digital Experience

Topic: Percutaneous Coronary Intervention (PCI)

Session: Coronary revascularisation focusing on outcomes

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources